Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab-Reference-Cited by-同舟云学术

Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab

Published:2003-08 Issue:4 Volume:30 Page:434-447
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Dillman Robert O.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference96 articles.

1. Follicular lymphoma: Have we made any progress?;Horning;Ann Oncol,2000

2. Low-grade lymphomas: Comparison of histologic classifications and survival rates for patients diagnosed during the last two decades;Dillman;Blood,2002

3. Antibodies as cytotoxic therapy;Dillman;J Clin Oncol,1994

4. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis;Golay;Blood,2000

5. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism;Cartron;Blood,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab-induced leukocytoclastic vasculitis in a patient with low-grade orbital B-cell lymphoma: a case report;Anti-Cancer Drugs;2024-07-23

2. A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections;Critical Reviews in Oncology/Hematology;2016-01

3. Rituximab (Rituxan®);Handbook of Therapeutic Antibodies;2014-08-12

4. Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101;Molecular Cancer Therapeutics;2011-01

5. Functional and Clinical Relevance of Chondroitin Sulfate Proteoglycan 4;Advances in Cancer Research;2010